Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Vitamin D and Calcium for Bone Health in HIV
NCT01403051Phase 2Completed
- Start
- Sep 2011
- Primary completion
- Feb 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in osteoporosis comparing EFV/FTC/TDF + Vitamin D3 + Calcium with EFV/FTC/TDF + Placebo (2 arms). Primary endpoint: Percent Change From Baseline in Bone Mineral Density (BMD) at Total Hip at 48 weeks. Started Sep 2011; status: completed.
02
Drugs
vitamin dcalcium carbonate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT01403051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01403051.